Evaluation of plasma insulin-like growth factor-binding protein-3 as a potential predictor of preeclampsia
- 1 October 1993
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 169 (4) , 995-999
- https://doi.org/10.1016/0002-9378(93)90042-h
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension aloneAmerican Journal of Obstetrics and Gynecology, 1991
- Preeclamptic Sera Stimulate Increased Platelet‐Derived Growth Factor mRNA and Protein Expression by Cultured Human Endothelial CellsAmerican Journal of Reproductive Immunology, 1991
- Women with Preeclampsia have Higher Plasma Endothelin Levels than Women with Normal PregnanciesJournal of Clinical Endocrinology & Metabolism, 1990
- Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancyAmerican Journal of Obstetrics and Gynecology, 1990
- Evidence of Enzymatic Degradation of Insulin-Like Growth Factor-Binding Proteins in the 150K Complex during Pregnancy*Journal of Clinical Endocrinology & Metabolism, 1990
- Partial Characterization of a Novel Growth Factor from the Blood of Women with Preeclampsia*Journal of Clinical Endocrinology & Metabolism, 1990
- Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1990
- Preeclampsia: An endothelial cell disorderAmerican Journal of Obstetrics and Gynecology, 1989
- Mitogenic activity is increased in the sera of preeclamptic women before deliveryAmerican Journal of Obstetrics and Gynecology, 1988
- Preeclampsia is associated with a serum factor cytotoxic to human endothelial cellsAmerican Journal of Obstetrics and Gynecology, 1988